The results of the twenty knowledge contest were announced.
Release time:
2023-05-04
News from our newspaper In mid-April, the group company's party committee, labor union, and youth league committee jointly organized the party's top 20 knowledge contest. The results of the contest have been announced a few days ago.
This competition adopts the online answer form. Participants scan the two-dimensional code through their mobile phones to enter the answer page and randomly answer 50 questions of 20 knowledge, with a full score of 100 points. During the week from April 13 to 19, a total of 989 employees participated in the answering questions, accounting for 47% of the total number of employees, of which 75 were full marks and 460 were above 90 points. Among all the subordinate units, Huang Ping Jianfeng, Health Technology Company and Cable Company participated in the competition, and the participation rate of employees from Jianfeng Pharmacy and Supply Chain Company also reached more than 95%.
According to the competition rules, the top three winners of the competition group award are Health Technology Company, Huang Ping Jianfeng and Jianfeng Pharmacy respectively. Lu Hongzheng and other 75 full-mark employees won individual awards (in order of the length of time they took to answer the questions, the list of winners is attached).
Award List
Group Award
First Place: Jianfeng Health Technology Company
Second Place: Guizhou Huangping Jianfeng Cement Company
Third Place: jianfeng Pharmacy Chain Co., Ltd.
Individual Award
First (1)
Lu Hongzheng
Second (2)
Pan Chaochun Huang Hongan
Third (72)
Long Jinxing Cai Chengbing Zhang Baoping Yuan Xianming
Zheng Kunwu Chen Daiyou Zhang Ting Zhang Dongdong
Jiang Lan Ying Yang Xinfeng Fang Xing King Sijia
Fu Junli Chen Jianhong Xu Li Zhen Feng Yilan
He Jing Sun Xiaofei Zhu Siqi Shao Shumei
Zou Xuecheng Zhou Hengbin Chen Jing Yu Xun
Xu Zhumei Jiang Yongjian Jin Wenwei Wang Siqi
Tang Songnian Chen Yu Miao Hu Xuechun Chen Jianfei
Hu Jiarong Yang Rong zhuo Ran
Tang Yuefen Yin Wu Feng Huifang Chen Anping
Lin Ronghua Lin Shunmei Ni Yingzhen Zhu Guoping
Luo Changcheng Zhao Chunquan Wang Liqin Lu Xianhui
Li Jiang Wang Jun Huang Zhaohui Chu Yu E
Zhang Jiangfeng Building Jianfeng Wang Xuesheng Chen Liangjun
Yang Liya Pei Xuefang Yang Ruichun Wang Li
Li
Zhou Jun Xu Xianzhong Wang Na Tian Yani
Song Shangfang Fang Xiaoping Zhu Dunbo Jiang Jing
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page